|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Departments of Internal Medicine (Dr. Chung-Ching Hua) and Pathology (Dr. Liang-Che Chang), Chang Gung Memorial Hospital, Keelung; the Chest Department (Ms. Yi-Chu Chen and Dr. Shi-Chuan Chang), Veterans General Hospital-Taipei, and the School of Medicine (Dr. Shi-Chuan Chang), National Yang-Ming University, Taipei, Taiwan, ROC.
Correspondence to: Shi-Chuan Chang, MD, PhD, FCCP, Chest Department, Veterans General Hospital-Taipei, #201, Section 2, Shih-Pai Rd, Taipei, Taiwan 11217, ROC
Objectives: To measure tumor necrosis factor-
(TNF-
) and interleukin-1ß (IL-1ß) in pleural effusions caused by
tuberculosis (TB) and malignancy and their relationship with
plasminogen activator inhibitor type I (PAI-1) and tissue type
plasminogen activator (tPA), and to compare the differences between
tuberculous and malignant pleural effusions. In addition, the
relationship between the effusion levels of these parameters and the
development of residual pleural thickening was evaluated in the
patients with tuberculous pleurisy.
Design: Prospective study.
Materials and methods: TNF-
,
IL-1ß, PAI-1, and tPA were measured simultaneously in blood and
pleural fluid using an enzyme-linked immunosorbent assay in 33 patients
with tuberculous and in 30 patients with malignant pleural effusions.
Residual pleural thickening was measured and defined as a pleural
thickness of
10 mm found on chest radiographs at the completion of
anti-TB chemotherapy in tuberculous pleurisy patients.
Results: In both groups, the levels of
proinflammatory cytokines and fibrinolytic enzymes were significantly
higher in pleural fluid than in blood. The levels of TNF-
and
PAI-1 were significantly higher in tuberculous than in malignant
effusions. In contrast, malignant pleural fluid had significantly
higher values of tPA than did tuberculous pleural fluid. In tuberculous
effusions, the values of PAI-1 and the PAI-1/tPA ratio correlated
positively and the levels of tPA correlated negatively with those of
TNF-
and IL-1ß. In malignant pleural fluid, positive correlations
were found between the values of proinflammatory cytokines (TNF-
and
IL-1ß) and PAI-1. Residual pleural thickening was found in 9 of 33
patients (27.3%) with tuberculous pleurisy. The pleural fluid values
of TNF-
, IL-1ß, and PAI-1 were significantly higher and the
concentrations of tPA were significantly lower in tuberculous pleurisy
patients with residual pleural thickening.
Conclusions: Compared to malignant pleural effusion,
fibrinolytic activity in pleural fluid was reduced in tuberculous
effusion. Pleural inflammation caused by TB may enhance the release of
proinflammatory cytokines, particularly TNF-
, which subsequently may
increase PAI-1 and decrease tPA in pleural fluid. The imbalance of
PAI-1 and tPA in pleural space may lead to fibrin deposition and
pleural thickening.
Key Words: fibrinolysis malignancy pleural effusion proinflammatory cytokines tuberculosis
This article has been cited by other articles:
![]() |
H.-J. Chen, W.-H. Hsu, C.-Y. Tu, Y.-H. Yu, K.-L. Chiu, L.-W. Hang, T.-C. Hsia, and C.-M. Shih Sonographic septation in lymphocyte-rich exudative pleural effusions: a useful diagnostic predictor for tuberculosis. J. Ultrasound Med., July 1, 2006; 25(7): 857 - 863. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-L. Chung, C.-H. Chen, J.-R. Sheu, Y.-C. Chen, and S.-C. Chang Proinflammatory Cytokines, Transforming Growth Factor-{beta}1, and Fibrinolytic Enzymes in Loculated and Free-Flowing Pleural Exudates Chest, August 1, 2005; 128(2): 690 - 697. [Abstract] [Full Text] [PDF] |
||||
![]() |
X-J. Qin, H-Z. Shi, Z-X. Huang, L-F. Kang, W-N. Mo, and C. Wu Interleukin-16 in tuberculous and malignant pleural effusions Eur. Respir. J., April 1, 2005; 25(4): 605 - 611. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-F. Chian, W.-L. Su, L.-H. Soh, H.-C. Yan, W.-C. Perng, and C.-P. Wu Echogenic Swirling Pattern as a Predictor of Malignant Pleural Effusions in Patients With Malignancies Chest, July 1, 2004; 126(1): 129 - 134. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ishikawa, H. Satoh, K. Sekizawa, C.-L. Chung, and S.-C. Chang Effect of Repeated Thoracenteses on Fibrinolytic Activity in Malignant Pleural Effusion Chest, May 1, 2004; 125(5): 1965 - 1966. [Full Text] [PDF] |
||||
![]() |
M. Weinstein, R. Restrepo, P. G. Chait, B. Connolly, M. Temple, and C. Macarthur Effectiveness and Safety of Tissue Plasminogen Activator in the Management of Complicated Parapneumonic Effusions Pediatrics, March 1, 2004; 113(3): e182 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-L. Chung, Y.-C. Chen, and S.-C. Chang Effect of Repeated Thoracenteses on Fluid Characteristics, Cytokines, and Fibrinolytic Activity in Malignant Pleural Effusion Chest, April 1, 2003; 123(4): 1188 - 1195. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. B. Bishop, S. Pon, H. M. Ushay, and B. M. Greenwald Alteplase in the Treatment of Complicated Parapneumonic Effusion: A Case Report Pediatrics, February 1, 2003; 111(2): e188 - 190. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |